Form 4: Elanco CEO to Acquire Additional Deferred Stock Units in Future Transaction

Elanco Animal Health Inc.'s President, CEO, and Director, Jeffrey N. Simmons, is scheduled to acquire 193.7887 deferred stock units on June 27, 2025, increasing his beneficial ownership to 16,849.4516 units.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., is scheduled to acquire 193.7887 Deferred Stock Units (DSUs) on June 27, 2025.
• Each DSU is valued at $14.29 and represents the right to receive one share of company common stock or its cash equivalent.
• Following this transaction, Mr. Simmons' total beneficial ownership of DSUs will increase to 16,849.4516 units.
• These DSUs are set to settle in cash or shares upon termination of employment or in a specified future year, in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The scheduled acquisition of deferred stock units by the President, CEO, and Director is generally viewed positively as it increases insider ownership and aligns executive interests with shareholder value, indicating confidence in the company's future.

Positives

• The scheduled acquisition of deferred stock units by the President, CEO, and Director, Jeffrey N. Simmons, on June 27, 2025, indicates a continued alignment of executive compensation with long-term company performance and shareholder interests.
• The increase in beneficial ownership of deferred stock units by a key executive reflects ongoing commitment and confidence in the company's future.

Negatives

• No direct negatives are apparent from this Form 4 filing, which reports a scheduled acquisition of deferred stock units.

Risks

• No specific risks are detailed in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• No direct management comments or quotes are provided in this Form 4 filing.

Industry Context

This Form 4 filing details an individual executive's compensation and ownership changes, which does not directly relate to broader industry trends or competitor analysis.

Comparison to Industry Standards

• This Form 4 filing, detailing an executive's deferred stock unit acquisition, does not provide information for comparison to specific industry benchmarks, comparable companies, projects, or results.

Related Party Transactions

• The scheduled acquisition of deferred stock units by the President, CEO, and Director, Jeffrey N. Simmons, is a transaction between the company and a related party (executive compensation).

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value due to increased beneficial ownership.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• No specific future actions, events, or milestones are detailed in this Form 4 filing.

Key Dates

Recommendation

Keywords

Elanco, ELAN, Form 4, insider transaction, deferred stock units, executive compensation, Jeffrey N. Simmons, beneficial ownership